"The evolution of the definition for high-risk multiple myeloma will help identify patients with light chain cast ... involving the immunoglobulin heavy chain (IgH) locus on chromosome 14q32.

is determined by demonstration of a monoclonal immunoglobulin molecule or chain in serum and/or urine. Previous results on immunofixation electrophoresis (IFE) and quantitative free light chain ...

Lonza’s bYlok® technology is changing the way bispecific antibodies are designed. Achieving the correct heterodimerization of light and heavy chains during bispecific production can be challenging, ...